Canada’s Regulators Maintain J&J Vaccine Over Emergent Hyperlink


Canada’s drug and vaccine regulator mentioned on Friday that it was withholding the discharge of the nation’s first cargo of the Johnson & Johnson vaccine to confirm its security and high quality.

Well being Canada, the regulator, mentioned on Tuesday that not one of the Johnson & Johnson vaccine, developed by the corporate’s Janssen subsidiary, had been made at an Emergent BioSolutions manufacturing unit in Baltimore which had discarded thousands and thousands of probably contaminated doses of AstraZeneca’s coronavirus vaccine.

However in an announcement issued on Friday night, it mentioned that since then it has “discovered {that a} drug substance produced on the Emergent web site was used within the manufacturing of the preliminary Janssen vaccines.”

The regulator mentioned that it’s now working with Janssen and the Meals and Drug Administration in america to be sure that the vaccines meet Canada’s requirements for “high quality, security and efficacy.”

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top